Predicting Survival in Bladder Cancer After Immunotherapy – LWW Journals
Predicting Survival in Bladder Cancer After ImmunotherapyLWW JournalsSAN FRANCISCO—Researchers have developed a model to predict overall survival for people with advanced urothelial cancers treated with the immune checkpoint inhibitor atezolizumab. The… Continue reading
